1. Multiple Myeloma: Challenges Encountered and Future Options for Better Treatment
   Srijit Das et al, 2022, International Journal of Molecular Sciences CrossRef
2. The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
   Yimei Feng et al, 2021, Frontiers in Oncology CrossRef
3. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions
   Abdelhakim Bouyahya et al, 2022, Biomolecules CrossRef
4. Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: Mechanisms insights and efficiencies
   Tarik Aanniz et al, 2024, Chemico-Biological Interactions CrossRef
5. Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition
   Maja Milošević et al, 2021, Frontiers in Nutrition CrossRef
6. CpG and Non-CpG Methylation in the Diet–Epigenetics–Neurodegeneration Connection
   Andrea Fuso et al, 2019, Current Nutrition Reports CrossRef
7. Target of Rapamycin Regulates Genome Methylation Reprogramming to Control Plant Growth in Arabidopsis
   Tingting Zhu et al, 2020, Frontiers in Genetics CrossRef
8. Expression of mTOR in normal and pathological conditions
   A Marques-Ramos et al, 2023, Molecular Cancer CrossRef
9. Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions
   Chao-Chao Yu et al, 2022, Frontiers in Pharmacology CrossRef
10. Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
    Sergi Herve Akone et al, 2020, Frontiers in Pharmacology CrossRef